Lin HY - Search Results

1

Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.

Yang SH, Lin HY, Changou CA, Chen CH, Liu YR, Wang J, Jiang X, Luh F, Yen Y. Yang SH, et al. Among authors: lin hy. Oncotarget. 2016 Jan 5;7(1):362-73. doi: 10.18632/oncotarget.6238. Oncotarget. 2016. PMID: 26517522 Free PMC article.

2

Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.

Lin HY, Su YF, Hsieh MT, Lin S, Meng R, London D, Lin C, Tang HY, Hwang J, Davis FB, Mousa SA, Davis PJ. Lin HY, et al. Among authors: lin s, lin c. FASEB J. 2013 Aug;27(8):3209-16. doi: 10.1096/fj.12-227132. Epub 2013 May 2. FASEB J. 2013. PMID: 23640055

3

Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3.

Incerpi S, Hsieh MT, Lin HY, Cheng GY, De Vito P, Fiore AM, Ahmed RG, Salvia R, Candelotti E, Leone S, Luly P, Pedersen JZ, Davis FB, Davis PJ. Incerpi S, et al. Among authors: lin hy. Am J Physiol Cell Physiol. 2014 Jul 15;307(2):C150-61. doi: 10.1152/ajpcell.00308.2013. Epub 2014 May 7. Am J Physiol Cell Physiol. 2014. PMID: 24808494 Free article.

4

Biologically active leptin-related synthetic peptides activate STAT3 via phosphorylation of ERK1/2 and PI-3K.

Lin HY, Yang SH, Tang HY, Cheng GY, Davis PJ, Grasso P. Lin HY, et al. Peptides. 2014 Jul;57:95-100. doi: 10.1016/j.peptides.2014.04.007. Epub 2014 May 10. Peptides. 2014. PMID: 24819473

5

Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro.

Chin YT, Hsieh MT, Yang SH, Tsai PW, Wang SH, Wang CC, Lee YS, Cheng GY, HuangFu WC, London D, Tang HY, Fu E, Yen Y, Liu LF, Lin HY, Davis PJ. Chin YT, et al. Among authors: lin hy. Oncotarget. 2014 Dec 30;5(24):12891-907. doi: 10.18632/oncotarget.2632. Oncotarget. 2014. PMID: 25436977 Free PMC article.

6

Low thyroid hormone levels improve survival in murine model for ocular melanoma.

Fabian ID, Rosner M, Fabian I, Vishnevskia-Dai V, Zloto O, Shinderman Maman E, Cohen K, Ellis M, Lin HY, Hercbergs A, Davis PJ, Ashur-Fabian O. Fabian ID, et al. Among authors: lin hy. Oncotarget. 2015 May 10;6(13):11038-46. doi: 10.18632/oncotarget.3566. Oncotarget. 2015. PMID: 25868390 Free PMC article.

7

Thyroid hormone and anti-apoptosis in tumor cells.

Lin HY, Glinsky GV, Mousa SA, Davis PJ. Lin HY, et al. Oncotarget. 2015 Jun 20;6(17):14735-43. doi: 10.18632/oncotarget.4023. Oncotarget. 2015. PMID: 26041883 Free PMC article. Review.

8

Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.

Yang SH, Lin HY, Chang VH, Chen CC, Liu YR, Wang J, Zhang K, Jiang X, Yen Y. Yang SH, et al. Among authors: lin hy. Oncotarget. 2015 Sep 15;6(27):23857-73. doi: 10.18632/oncotarget.4408. Oncotarget. 2015. PMID: 26160843 Free PMC article.

9

Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status.

Chin YT, Yang SH, Chang TC, Changou CA, Lai HY, Fu E, HuangFu WC, Davis PJ, Lin HY, Liu LF. Chin YT, et al. Among authors: lin hy. Oncotarget. 2015 Nov 3;6(34):35866-79. doi: 10.18632/oncotarget.5482. Oncotarget. 2015. PMID: 26456774 Free PMC article.

10

Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin.

Yang YC, Chin YT, Hsieh MT, Lai HY, Ke CC, Crawford DR, Lee OK, Fu E, Mousa SA, Grasso P, Liu LF, Chang HY, Tang HY, Lin HY, Davis PJ. Yang YC, et al. Among authors: lin hy. Oncotarget. 2016 May 10;7(19):27641-54. doi: 10.18632/oncotarget.8505. Oncotarget. 2016. PMID: 27050378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,733 results

Search Page